SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Checkpoint Trends submit scrutinizer report

01 Oct 2024 Evaluate

Checkpoint Trends has submitted the following with respect to 33rd Annual General Meeting of the company (‘Formerly known as Rubra Medicaments’), held on Monday, September 30, 2024 at 10:00 am (IST) through Video Conferencing (VC) / Other Audio Visual Means (OAVM), without the physical presence of the Members at a common venue. All the resolutions have been passed with requisite majority by way of remote e-voting: Scrutinizer Report pursuant to Section 108 of the Companies Act, 2013 and Rule 20(4)(xii) of the Companies (Management and Administration) Rules, 2014. The same will be made available on the Company’s website at http://www.rubramed.com/

The above information is a part of company’s filings submitted to BSE.


Rubra Medicaments Share Price

58.44 2.78 (4.99%)
16-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 228.00
Adani Enterprises 2205.00
Amrapali Industries 17.35
Rashi Peripheral 456.80
PDS 300.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×